Can we prevent sudden cardiac death in dialysis patients?

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 3, 2007, Pages 410-412

  Herzog, Charles A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT;

CHRONIC KIDNEY FAILURE; DEFIBRILLATOR; HUMAN; NOTE; RENAL REPLACEMENT THERAPY; SUDDEN DEATH;

CARDIOTONIC AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 34748857315     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01130307     Document Type: Editorial

References (21)

1. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Maryland, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
2. Cheung AK, Sarnak MJ, Guofen Y, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco MV, Toto R, Windus D, Ornt D, Levey AS: Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int 65: 2380-2389, 2004
3. Wanner C, Krane V, Marz W, Olschewski M, Mann JFE, Ruf G, Ritz E; the German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
4. Herzog CA, Strief JW, Collins AJ, Gilbertson DT. Cause-specific mortality of dialysis patients after coronary revascularization: Why don't dialysis patients have better survival after coronary intervention? [Abstract] Circulation 110[Suppl]: III-493, 2004
5. Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG: Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 69: 1839-1845, 2006
6. Herzog CA: Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome Kidney Int 63[Suppl 84]: S197-S200, 2003
7. Amann K, Rychlik I, Miltenberger-Milteny G, Ritz E: Left ventricular hypertrophy in renal failure. Kidney Int 54 [Suppl 68]: S78-S85, 1998
8. Amann K, Ritz E: Cardiac disease in chronic uremia: Pathophysiology. Adv Ren Replace Ther 4: 212-224, 1997
9. Ritz E, Amann K, Tornig J, Schwarz U, Stein G: Some cardiac abnormalities in renal failure. Adv Nephrol Necker Hosp 27: 85-103, 1997
10. Amann K, Buzello M, Simonaviciene A, Miltenberger-Miltenyi G, Koch A, Nabokov A, Gross ML, Gless B, Mall G, Ritz E: Capillary/myocyte mismatch in the heart in renal failure: A role for erythropoietin? Nephrol Dial Transplant 15: 964-969, 2000
11. US Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Maryland, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
12. US Renal Data System: USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Maryland, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
13. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM: Cardiac arrest and sudden death in dialysis units. Kidney Int 60: 350-357, 2001
14. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69: 2268-2273, 2006
15. Lehrich RW, Pun PH, Tanenbaum ND, Smith SR, Middleton JP: Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 18: 312-320, 2007
16. Pun PH, Lehrich RW, Smith SR, Middleton JP: Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2: 491-500, 2007
17. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Circulation 114: 1088-1132, 2006
18. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT: Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68: 818-825, 2005
19. Cice G, Ferrara L D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Paolo Golino P, Calabro R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol 41: 1438-1444, 2003
20. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70: 1318-1324, 2006
21. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y: Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis: A randomized study. Nephrol Dial Transplant 21: 2507-2512, 2006